Dasatinib (Tasigna® and generic brands) — Patient-Friendly Guide (Australia)

Dasatinib is an oral medicine used to treat certain cancers of the blood and bone marrow. It belongs to a class of targeted therapies designed to block specific proteins that help cancer cells grow and survive. This guide explains how dasatinib works, how it is used, what to expect, and important safety considerations for people in Australia.

Always follow the guidance provided by your treating team. Information below is designed to help you understand your medicine and discuss any questions with a health professional.

1) Basic product information

2) How dasatinib works (mechanism of action)

Many forms of leukaemia are driven by abnormal signalling proteins. In particular, dasatinib inhibits multiple tyrosine kinases, including:

• BCR-ABL1 (including the BCR-ABL fusion protein seen in chronic myeloid leukaemia, CML)
• Other kinases involved in blood cell signalling (such as SRC family kinases)

By blocking these signals, dasatinib helps to:

• Reduce cancer cell growth
• Decrease the ability of cancer cells to survive
• Help achieve haematologic and molecular responses over time

Dasatinib is considered a targeted therapy, meaning it acts on specific molecular pathways rather than broadly attacking rapidly dividing cells.

3) Pharmacokinetics (how the body handles it)

Pharmacokinetics describes how the body absorbs, distributes, metabolises, and eliminates a medicine. While individual results can vary, these are key points relevant to everyday use:

• Absorption: Dasatinib absorption can be significantly affected by food. Food may increase exposure unpredictably.
• Peak levels: Blood concentrations rise after dosing, then decline as the medicine is metabolised.
• Metabolism: Mainly metabolised in the liver (primarily via CYP3A4 pathways).
• Elimination: Metabolites are eliminated mainly through faeces and to a lesser extent through urine.
• Half-life: The effective duration supports dosing schedules that may be once or twice daily depending on the regimen.

Because metabolism involves liver enzymes, other medicines can affect dasatinib levels, potentially increasing side effects or reducing effectiveness.

4) Typical use in Australia (indications)

Dasatinib is used for specific blood cancers where targeted kinase activity is present. Indications may vary by jurisdiction and product listing; your clinician will confirm the appropriate use for your situation.

Common clinical uses include:

• Chronic myeloid leukaemia (CML) — including chronic phase, accelerated phase, or blast crisis in appropriate patients
• Philadelphia chromosome–positive acute lymphoblastic leukaemia (Ph+ ALL) — in certain adult or paediatric settings depending on eligibility and prior treatments

In practice, clinicians use disease phase, prior therapy history, and molecular testing (including BCR-ABL1 markers) to determine suitability and expected response monitoring.

5) Timing and how to take dasatinib

One of the most important practical aspects of dasatinib is food timing. Correct timing helps maintain safe and effective blood drug levels.

General advice:

• Take consistently: Aim to take your doses at the same times each day.
• Follow your specific fasting instructions: Your medicine information will include exact guidance. Many dasatinib regimens require:
  • Taking doses without food or after a fasting period
  • Waiting after the dose before eating
• Do not crush or split tablets: Swallow tablets whole unless your product instructions state otherwise.

If you miss a dose, do not double up. Contact your treating team or pharmacist for instructions on what to do in your specific case.

6) Food interactions (what to avoid)

Food can affect how much dasatinib your body absorbs. This is why many patients are instructed to take dasatinib under defined fasting conditions.

• Avoid taking with meals unless your clinician’s instructions or your product information explicitly allow it.
• Plan snacks carefully: Eating too close to dosing can increase exposure and raise the risk of side effects.
• Use consistent routines: If your day varies, set reminders and plan meals around dosing times.

If you’re unsure about your personal schedule (for example, shift work, childcare routines, or other dietary needs), ask your pharmacist to help build a practical timing plan.

7) Alcohol interactions

Alcohol may not have a direct “known” interaction with dasatinib in all cases, but it can increase risk in practical ways:

• Increased fatigue or dizziness: Alcohol can worsen tiredness, weakness, or light-headedness.
• Liver strain: Dasatinib is processed by the liver. Alcohol intake may add additional liver stress, especially with heavy or regular use.
• Higher risk of nausea: Both alcohol and cancer therapies can cause nausea or stomach upset.

For many people, moderate or occasional alcohol may be discussed with the treating team. If you have liver problems, ongoing elevated liver enzymes, or significant treatment side effects, it’s especially important to ask before drinking.

8) Medicine interactions (important drug–drug effects)

Because dasatinib is metabolised by liver enzymes (notably CYP3A4), several medicine categories can significantly affect its levels.

Common interaction themes:

• Strong enzyme inhibitors can raise dasatinib levels and increase side effects.
• Strong enzyme inducers can lower dasatinib levels and reduce effectiveness.
• Acid-reducing medicines (for example, some antacids and acid suppressors) may affect absorption depending on the product and timing.

Examples of medicines that require extra caution (not exhaustive):

• Antifungals and some antibiotics that affect CYP enzymes
• Anticonvulsants (some can reduce levels)
• St John’s wort (Hypericum perforatum) — can reduce medicine effectiveness
• Acid reducers including proton pump inhibitors (PPIs), H2 blockers, and certain antacids (timing may be critical)
• Other cancer therapies — may overlap in side-effect risks

What to do: Keep an up-to-date list of all medicines, including over-the-counter products and supplements. Share it with your pharmacist before starting or stopping anything.

9) Dosing overview (general information)

Dasatinib dosing depends on the specific indication, patient factors, treatment history, and response. Your clinician will prescribe the most appropriate dose and schedule.

Typical dosing patterns (examples):

• Many adult regimens are taken twice daily (morning and evening), though schedules vary by indication and age group.
• Dose may be adjusted based on blood test results, side effects, and treatment response.

Do not change your dose without advice. If you experience intolerable side effects, your doctor may recommend interruption, dose reduction, or supportive treatment.

If you have kidney problems, your clinician will assess whether any adjustments are needed. Liver impairment can influence exposure and should be discussed promptly.

10) Safety profile and side effects

Like all medicines, dasatinib can cause side effects. Many are manageable with monitoring and supportive care. Some side effects require urgent medical attention.

Common side effects

• Low blood counts (anaemia, neutropenia, thrombocytopenia) — may increase infection risk or bruising/bleeding
• Fatigue and weakness
• Nausea, diarrhoea, constipation, or stomach discomfort
• Headache or dizziness
• Rash or skin changes
• Muscle or joint pain
• Fluid retention (some people experience swelling)

Important risks (seek medical advice promptly)

• Bleeding or unusual bruising (possible low platelets)
• Signs of infection (fever, chills, persistent sore throat)
• Shortness of breath, chest pain, or persistent cough (may indicate fluid around the lungs, infection, or other serious conditions)
• Severe allergic reactions (swelling of face/lips, difficulty breathing, widespread hives)
• Serious heart or circulation symptoms (e.g., fainting, significant palpitations)
• Liver-related changes (yellowing skin/eyes, dark urine, marked fatigue)

Your clinic will typically perform regular blood tests to monitor blood counts and sometimes liver function. Always report new symptoms early.

Monitoring and tests

• Full blood counts (FBC) to track white cells, haemoglobin, and platelets
• Liver function tests
• Electrocardiogram (ECG) and other assessments if clinically indicated
• BCR-ABL1 molecular monitoring at intervals to assess response

11) Practical use tips (for day-to-day success)

• Set reminders: Consistent timing is especially important with food restrictions.
• Plan meals around dosing: If your regimen includes fasting periods, schedule breakfast/lunch/dinner accordingly.
• Hydration matters: Maintain regular fluid intake unless your doctor advises otherwise.
• Track side effects: Keep a simple log of symptoms, timing, and severity to help your clinician fine-tune treatment.
• Prevent infection risk: Practise good hygiene; ask your team how to manage fever or low neutrophil counts.
• Careful with bleeding: Use a soft toothbrush and avoid high-risk activities if platelets are low.
• Medication list: Carry your current medication list when attending appointments or emergencies.

If you have vomiting soon after taking a dose, ask your pharmacist whether you should take another dose or wait—recommendations can vary depending on how soon the dose was taken and your clinical plan.

12) Alternative options (what else may be considered)

Treatment choices for CML or Ph+ ALL can vary based on response, tolerance, prior therapies, and molecular findings. Alternatives may include other tyrosine kinase inhibitors or other treatment strategies.

Potential alternatives (depending on your condition):

• Other tyrosine kinase inhibitors used in CML/Ph+ ALL (choice depends on line of therapy and response)
• Monoclonal antibodies, chemotherapy, or transplant approaches in selected cases
• Supportive care medicines to manage side effects (e.g., treatments for nausea, anaemia support, or infection prevention strategies)

Your treating team can explain why dasatinib was chosen for you and what options exist if it isn’t tolerated or if response is inadequate.

13) Market and legal context for Australia

In Australia, access to anticancer medicines typically occurs through a combination of specialist prescribing, hospital supply arrangements, and the Pharmaceutical Benefits Scheme (PBS) where listed. Eligibility and listings can differ based on diagnosis, treatment line, and other clinical criteria.

Online pharmacy services in Australia must operate under applicable state and Commonwealth regulations, including requirements around:

• Verified patient identity and supply processes
• Appropriate handling and transport to maintain medicine quality
• Secure medication communication and counselling
• Compliance with listed indications and supply criteria

If you’re using an online service, check that it is an Australian-registered pharmacy and that it provides appropriate medication information and delivery options.

14) Recent guidance and best-practice considerations

While specific recommendations change as new evidence emerges, commonly updated guidance for TKIs like dasatinib focuses on:

• Optimising timing with food to improve consistency and safety
• Close monitoring for fluid retention/respiratory symptoms
• Drug interaction screening (especially acid suppressors and CYP3A4-related interactions)
• Managing cardiovascular and blood-related risks with regular clinical review
• Adherence support because missed doses can affect response

Your local oncology service can provide the most current recommendations for your specific regimen and product form.

15) Delivery, storage, and availability (Australia)

Online pharmacies typically deliver dasatinib in line with medicines-handling requirements. Availability may vary depending on stock levels and product demand.

Delivery

• Dispatch times: Vary by supplier and local stock availability.
• Packaging: Medicines should arrive in intact, labelled packaging.
• Delivery address: Use a safe, secure location where the parcel can be received promptly.

Storage

• Store according to the label instructions (typically at controlled room temperature).
• Keep out of sight and reach of children.
• Check expiry dates before use.

If packaging appears damaged or tablets look unusual, contact the supplier or pharmacist before using.

16) FAQ — Dasatinib

1. What is dasatinib used for?

Dasatinib is used to treat certain blood cancers, most commonly chronic myeloid leukaemia (CML) and Philadelphia chromosome–positive acute lymphoblastic leukaemia (Ph+ ALL), depending on your disease phase and prior treatments.

2. How should I take dasatinib with food?

Food timing is critical. Many regimens require fasting around the dose (either taking without food or waiting for a specified period after eating). Follow the exact instructions on your product information or the directions provided by your healthcare team.

3. Can I drink alcohol while taking dasatinib?

Alcohol is not always strictly prohibited, but it may worsen side effects (fatigue, nausea, dizziness) and may add liver stress. Discuss your alcohol intake with your treating team, especially if you have liver issues or ongoing treatment side effects.

4. What medicines can interact with dasatinib?

Dasatinib interacts with medicines that affect liver enzymes (particularly CYP3A4) and certain acid-reducing products. Always provide a complete list of prescription medicines, over-the-counter products, and supplements to your pharmacist.

5. What side effects are most common?

Common side effects include fatigue, nausea, diarrhoea/constipation, rash, and changes in blood counts (anaemia, neutropenia, or low platelets).

6. When should I seek urgent help?

Seek urgent medical advice if you develop symptoms such as fever or infection signs, unusual bleeding or severe bruising, significant shortness of breath, chest pain, fainting, or signs of a serious allergic reaction.

7. If I miss a dose, what should I do?

Do not double the dose. Contact your pharmacist or treating team for advice. The correct approach depends on how close you are to the next scheduled dose.

8. How often will I need blood tests?

Frequency varies by regimen and clinical response, but it is often regular at the beginning and adjusted over time. Typical monitoring includes full blood counts and sometimes liver function tests, plus molecular monitoring for response.

9. Are there alternative treatments if dasatinib doesn’t work for me?

Yes. Depending on your response and side effects, your clinician may consider other tyrosine kinase inhibitors or other treatment approaches. Options depend on your disease type, phase, and treatment history.

10. Is dasatinib available through online pharmacies in Australia?

Availability depends on product listings, stock levels, and supply arrangements. Choose a reputable Australian-registered pharmacy that can provide counselling, clear product information, and appropriate delivery.

17) Summary

Dasatinib is a targeted oral medicine used for specific blood cancers such as CML and Ph+ ALL. It works by inhibiting cancer-related tyrosine kinases, particularly BCR-ABL1. Because food can significantly affect absorption, and because interactions with other medicines can change dasatinib levels, taking it correctly and keeping up with monitoring is essential.

If you have questions about timing, side effects, or interactions, speak with your pharmacist or oncology team. They can help you create a safe, practical schedule that fits your lifestyle.